Recent ISPC News
- iSpecimen Reports Full Year 2023 Results • GlobeNewswire Inc. • 03/14/2024 12:00:00 PM
- iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call • GlobeNewswire Inc. • 03/12/2024 11:07:37 PM
- iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 02:26:44 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/05/2024 02:24:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:09:04 PM
- Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:10:16 PM
- iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research • GlobeNewswire Inc. • 01/23/2024 12:30:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024 • GlobeNewswire Inc. • 01/18/2024 01:11:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:15:19 PM
- iSpecimen Strengthens Global Oncology Biospecimen Offering • GlobeNewswire Inc. • 12/07/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 01:01:04 PM
- iSpecimen Reports Third Quarter 2023 Financial and Operating Results • GlobeNewswire Inc. • 11/02/2023 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 10:30:39 AM
- iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research • GlobeNewswire Inc. • 10/26/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 11:45:11 AM
- iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially • GlobeNewswire Inc. • 10/23/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 09:29:04 PM
- iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers • GlobeNewswire Inc. • 09/28/2023 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 08:23:45 PM
- iSpecimen Expands Provider Network to Enhance Support for Women’s Health Research • GlobeNewswire Inc. • 09/13/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 08:16:48 PM
- iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability • GlobeNewswire Inc. • 09/06/2023 08:05:00 PM
- iSpecimen Launches New Virtual Cancer Sequencing Procurement Program • GlobeNewswire Inc. • 08/30/2023 11:30:00 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM